Biodol Therapeutics made a breakthrough discovery on the origin and maintenance of NP.
Biodol Therapeutics has raised $7.6M in total funding. The most recent round was Undisclosed. The last funding was announced in May 2024.
Biodol Therapeutics's investors include Bpifrance, V-Bio Ventures.
Biodol Therapeutics is headquartered in Clapiers, France.
Biodol Therapeutics made a breakthrough discovery on the origin and maintenance of NP.
Biodol Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biodol Therapeutics — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/biodol-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). Biodol Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/biodol-therapeutics
{{cite web |title=Biodol Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/biodol-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated